Results 51 to 60 of about 34,488 (237)
Nanozymes as Enzyme Inhibitors
Yaling Huang,1 Jian Jiang,1 Yanqiu Wang,1 Jie Chen,1 Juqun Xi1,2 1Institute of Translational Medicine, Department of Pharmacology, School of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225001, People’s Republic of China; 2Jiangsu Key ...
Huang Y, Jiang J, Wang Y, Chen J, Xi J
doaj
Asymmetric single‐atom metal‐nitrogen‐carbon catalysts modulate the non‐radical pathway during peroxymonosulfate (PMS) activation. A fundamental contrast was revealed between diffusible singlet oxygen (1O2) and non‐diffusible electron‐transfer pathways (ETP) in antibiotic resistance gene (ARG) degradation.
Chen Gao +6 more
wiley +1 more source
Structure based drug design: the discovery of novel inhibitors active against New Delhi Metallo-β-lactamase-1 [PDF]
Background. The emergence of bacterial strains resistant to available antibiotic armamentarium is nowadays a pressing issue in clinical therapy. Among the several mechanisms of bacterial resistance, the rapid evolution and spread of carbapenemases, β ...
Cross, Simon +7 more
core
Schematic diagrams illustrating the breakthrough in the screening of AChE inhibitors from LBL, and the research process of the pharmacodynamics of the NCP are presented. ABSTRACT Current Alzheimer's drugs exhibit limited effectiveness, highlighting the necessity for multi‐target treatments.
Yuping Sa +11 more
wiley +1 more source
Synthesis and rearrangement of potential zinc beta-lactamase inhibitors. [PDF]
On alkylation of the p-toluene sulfonic salt of benzyl 6-aminopenicillanate (6-APA) with benzyl 2-bromoacetate, the benzyl esters of N-(benzyloxycarbonylmethyl)-6-APA (1) and of N,N-di(benzyloxycarbonylmethyl)-6-APA (3) were obtained. Hydrogenolysis of 1
Vanwetswinkel, S. +3 more
core +1 more source
The investigation of the new beta-lactamase inhibitors [PDF]
Klinikte kullanımda olan beta-laktamazları geri dönüşümsüz olarak inhibe eden 3 farklı inhibitör söz konusudur; bunlar klavulanik asit, sulbaktam ve tazobaktamdır.
H. Karaca +3 more
openaire +3 more sources
In vitro and in silico screening of Klebsiella pneumoniae new Delhi metallo-β-lactamase-1 inhibitors from endophytic Streptomyces spp. [PDF]
The increase in drug resistance over the last two decades is a big threat in health care settings. More importantly, the dissemination of carbapenem-resistant Enterobacteriaceae is the major threat to public health with an increase in morbidity and ...
Aathithya Diaz (11572536) +5 more
core +1 more source
Probing the Role of Asn 152 in the Class C β-lactamase AmpC [PDF]
AmpC, a class C β-lactamase, is a main cause of antibiotic resistance to cephalosporins in many species of bacteria. The current proposed mechanism of action involves an acyl-intermediate, where the enzyme becomes covalently attached to the drug at ...
Powers, Rachel +4 more
core +1 more source
Fluoroquinolones versus beta-Lactam/beta-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study [PDF]
Background ;Studies on the association between antibiotic treatment and outcomes in outpatients with chronic obstructive pulmonary disease (COPD) and pneumonia are scarce. This study aimed to evaluate the effectiveness of fluoroquinolones and beta-lactam/
Lin, Kuan-Yin;Wang, Chi-Chuan;Lin, Chia-Hui;Sheng, Wang-Huei;Chang, Shan-Chwen +1 more
core +1 more source
Objective: There is an increased prevalence of extended-spectrum beta-lactamase producing Klebsiella pneumoniae (ESBL-KP) worldwide including India, which is a major concern for the clinicians, especially in intensive care units and pediatric patients ...
Amit Kumar Singh +4 more
doaj +1 more source

